<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04266340</url>
  </required_header>
  <id_info>
    <org_study_id>20180341</org_study_id>
    <nct_id>NCT04266340</nct_id>
  </id_info>
  <brief_title>Different Premedication in Children</brief_title>
  <official_title>Effects of Different Premedication on Preoperative Sedation and Postoperative Agitation in Children Undergoing Ophthalmic and Otorhinolaryngologic Operations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eye &amp; ENT Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eye &amp; ENT Hospital of Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators studied the effects of intranasal dexmedetomidine compared with oral
      midazolam with different doses for premedication in children. One hundred and twenty children
      aged between 2 and 12 years were randomly allocated to one of four groups:2.5µg/kg intranasal
      dexmedetomidine group ; 0.5mg/kg oral midazolam group;0.05 mg/kg intravenous injection
      midazolam group; no premedication group.

      Sedation levels 10, 20, and 30min after premedication were evaluated using a 5-point sedation
      scale. A 4-point emotional state score was used to evaluate participators when they were
      separated from their parents and their response to intravenous cannulation or facemask
      application. Agitation scores (Pediatric Anesthe-sia Emergence Delirium [PAED] scale) and POV
      were assessed in the postanesthetic care unit (PACU).Times to endotracheal tube or laryngeal
      mask airway removal, discharge from the PACU and patients' satisfaction degree were also
      assessed.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 13, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sedation</measure>
    <time_frame>10 minutes after premedication</time_frame>
    <description>Rarely awake, needs shaking or shouting to wake up
Asleep, eyes closed, wakes up when called softly or lightly touched
Sleepy but eyes open spontaneously
Awake
Agitated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sedation</measure>
    <time_frame>20 minutes after premedication</time_frame>
    <description>Rarely awake, needs shaking or shouting to wake up
Asleep, eyes closed, wakes up when called softly or lightly touched
Sleepy but eyes open spontaneously
Awake
Agitated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sedation</measure>
    <time_frame>30 minutes after premedication</time_frame>
    <description>Rarely awake, needs shaking or shouting to wake up
Asleep, eyes closed, wakes up when called softly or lightly touched
Sleepy but eyes open spontaneously
Awake
Agitated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional state</measure>
    <time_frame>0 minutes after they were separated from their parents</time_frame>
    <description>Calm
Apprehensive, not smiling, tentative behaviour, withdrawn
Crying
Thrashing, crying with movement of arms and legs, resisting</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional state</measure>
    <time_frame>0 minutes after intravenous cannulation</time_frame>
    <description>Calm
Apprehensive, not smiling, tentative behaviour, withdrawn
Crying
Thrashing, crying with movement of arms and legs, resisting</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional state</measure>
    <time_frame>0 minutes after facemask application</time_frame>
    <description>Calm
Apprehensive, not smiling, tentative behaviour, withdrawn
Crying
Thrashing, crying with movement of arms and legs, resisting</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Agitation</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no premedication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oralmidazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5 mg/kg oral midazolam group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intravenous midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.05 mg/kg intravenous injection midazolam group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.5µg/kg intranasal dexmedetomidine group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine</intervention_name>
    <description>2.5µg/kg intranasal dexmedetomidine group</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midazolam</intervention_name>
    <description>0.5mg/kg oral midazolam</description>
    <arm_group_label>oralmidazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midazolam</intervention_name>
    <description>0.05mg/kg intravenous injection midazolam</description>
    <arm_group_label>intravenous midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>no premedication</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -

        Exclusion Criteria:

          -  a recent history of upper respiratory tract infection, a known allergy to
             dexmedetomidine or midazolam, inability to understand the consent process or parental
             refusal.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 13, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2020</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

